It may be our longing for friends and family. It may be instinctive. It may be that we’re exhausted. Whatever the reasons, many of us see familiar people as less of a COVID-19 risk, psychologists say.
This phenomenon is not about people inside your household. And it reaches beyond social pods – which heath experts say are often iffy. New studies show that we almost instinctively drop our guard with people we know although we often have no clue about their health protocols.
As COVID-19 sweeps the world, related viruses quietly circulate among wild animals. A new study shows how SARS-CoV-2, the virus that causes COVID-19, and SARS-CoV-1, which caused the 2003 SARS outbreak, are related to each other. The work, published recently in the journal Virus Evolution, helps scientists better understand the evolution of these viruses, how they acquired the ability to infect humans and which other viruses may be poised for human spillover.
There is bad news and good news about the COVID-19 variants emerging around the world and in California.
The bad news: Studies show three major variants, the ones first found in the United Kingdom, South Africa and Brazil, are more infectious, cause more serious cases of COVID-19 and increase the risk of dying.
There is bad news and good news about the COVID-19 variants emerging around the world and in California.
The bad news: Studies show three major variants, the ones first found in the UK, South Africa and Brazil, are more infectious, cause more serious cases of COVID-19 and increase the risk of dying.
Through its free community COVID-19 test operations, Healthy Davis Together and the UC Davis Genome Center identified the first known case of the B.1.1.7 variant of the virus SARS-CoV-2 in the Sacramento region.
News reports indicate COVID-19 vaccines are not getting out soon enough nor in adequate supplies to most regions, but there may be a larger underlying problem than shortages. A University of California, Davis, study found that more than a third of people nationwide are either unlikely or at least hesitant to get a COVID-19 vaccine when it becomes available to them.
One year after the first patient with COVID-19 was diagnosed in the U.S., the world is still searching for safe and effective drugs to treat the coronavirus. UC Davis School of Medicine researchers have partnered with many drug developers to test potential therapies and vaccines. Currently, they are recruiting for more than 12 clinical trials to find potent COVID-19 treatments.
